Member of Lyonbiopole
Synthelis is a service provider (CRO) for recombinant protein production using a proprietary cell-free expression system. Synthelis technology and know-how address difficult-to-express proteins with standard cell-based expression systems. The major proteins concerned are membrane proteins as well as cytotoxic proteins.
The Synthelis offering is divided up into the following areas:
- Expression feasibility phase
- Activity validation phase (using SPR, patch-clamp…)
- Optimization phase to improve activity levels or purity rates
- Scale-up of production (several milligrams / month)Synthelis is also developing new approaches for protein therapy and vaccine development based on membrane protein delivery by liposomal vectors.
Strategic application domain: Human Medicine
Application market: Infectious Diseases, Oncology
Type of activity: CRO - Tools - R&D platform, Therapeutics, Pharma or Biotech
Technologies: Antibodies - Protein - Peptide, Drug delivery device & Technologies
Created on jan. 3rd, 2011 - 9 employees
Address
5 avenue du Grand Sablon 38700 La Tronche
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.